Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Saddler

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
Transplant Infectious Disease : an Official Journal of the Transplantation Society|January 29, 2019
Outcomes of Norovirus diarrheal infections and Clostridioides difficile infections in kidney transplant recipients: A single-center retrospective studyStacey Rolak, Sarah Di Bartolomeo, Margaret R Jorgenson, et al.
Clinical Transplantation|June 15, 2026
Improved Tolerability of De Novo Letermovir Over Valganciclovir for Cytomegalovirus Prophylaxis in Seropositive Liver Transplant RecipientsHanna L Kleiboeker, Jillian L Descourouez, Chris M Saddler, et al.
Clinical Transplantation|January 30, 2020
Management of BK viremia is associated with a lower risk of subsequent cytomegalovirus infection in kidney transplant recipientsMargaret R Jorgenson, Jillian L Descourouez, Beini Lyu, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|November 20, 2021
Letermovir conversion after valganciclovir treatment in cytomegalovirus high-risk abdominal solid organ transplant recipients may promote development of cytomegalovirus-specific cell mediated immunityMargaret R Jorgenson, Hanna Kleiboeker, Neetika Garg, et al.
Clinical Transplantation|September 27, 2023
Real world experience with conversion from valganciclovir to letermovir for cytomegalovirus prophylaxis: Letermovir reverses leukopenia and avoids mycophenolate dose reductionMargaret R Jorgenson, Jillian L Descourouez, Christopher M Saddler, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|July 3, 2022
Risk factors for high level cytomegalovirus viremia in liver transplant recipients and associated outcomesHanna L Kleiboeker, Margaret R Jorgenson, Glen E Leverson, et al.
Clinical Transplantation|May 21, 2021
Bimonthly viral monitoring for late-onset cytomegalovirus infection-Balancing efficacy with patient palatability; A reply to Melgarejo et alMelissa M Durst, Margaret R Jorgenson, Jillian L Descourouez, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|July 26, 2021
The addition of adjunctive letermovir to valganciclovir for refractory cytomegalovirus viremia in kidney transplant recipientsMargaret R Jorgenson, Jillian L Descourouez, Neetika Garg, et al.
The Annals of Pharmacotherapy|January 16, 2025
The UW Experience: Feasibility of De Novo Letermovir for Primary Prophylaxis After Abdominal Solid Organ TransplantJillian L Descourouez, Hanna Kleiboeker, Christopher M Saddler, et al.
Transplantation Proceedings|February 14, 2024
Resource Use and Financial Impact of Oral Step-Down Therapy for Resistant Cytomegalovirus in Solid Organ Transplant RecipientsHanna Kleiboeker, Jillian L Descourouez, Lucas T Schulz, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Transplant Infectious Disease : an Official Journal of the Transplantation Society|January 29, 2019
Outcomes of Norovirus diarrheal infections and Clostridioides difficile infections in kidney transplant recipients: A single-center retrospective studyStacey Rolak, Sarah Di Bartolomeo, Margaret R Jorgenson, et al.
Clinical Transplantation|June 15, 2026
Improved Tolerability of De Novo Letermovir Over Valganciclovir for Cytomegalovirus Prophylaxis in Seropositive Liver Transplant RecipientsHanna L Kleiboeker, Jillian L Descourouez, Chris M Saddler, et al.
Clinical Transplantation|January 30, 2020
Management of BK viremia is associated with a lower risk of subsequent cytomegalovirus infection in kidney transplant recipientsMargaret R Jorgenson, Jillian L Descourouez, Beini Lyu, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|November 20, 2021
Letermovir conversion after valganciclovir treatment in cytomegalovirus high-risk abdominal solid organ transplant recipients may promote development of cytomegalovirus-specific cell mediated immunityMargaret R Jorgenson, Hanna Kleiboeker, Neetika Garg, et al.
Clinical Transplantation|September 27, 2023
Real world experience with conversion from valganciclovir to letermovir for cytomegalovirus prophylaxis: Letermovir reverses leukopenia and avoids mycophenolate dose reductionMargaret R Jorgenson, Jillian L Descourouez, Christopher M Saddler, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|July 3, 2022
Risk factors for high level cytomegalovirus viremia in liver transplant recipients and associated outcomesHanna L Kleiboeker, Margaret R Jorgenson, Glen E Leverson, et al.
Clinical Transplantation|May 21, 2021
Bimonthly viral monitoring for late-onset cytomegalovirus infection-Balancing efficacy with patient palatability; A reply to Melgarejo et alMelissa M Durst, Margaret R Jorgenson, Jillian L Descourouez, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|July 26, 2021
The addition of adjunctive letermovir to valganciclovir for refractory cytomegalovirus viremia in kidney transplant recipientsMargaret R Jorgenson, Jillian L Descourouez, Neetika Garg, et al.
The Annals of Pharmacotherapy|January 16, 2025
The UW Experience: Feasibility of De Novo Letermovir for Primary Prophylaxis After Abdominal Solid Organ TransplantJillian L Descourouez, Hanna Kleiboeker, Christopher M Saddler, et al.
Transplantation Proceedings|February 14, 2024
Resource Use and Financial Impact of Oral Step-Down Therapy for Resistant Cytomegalovirus in Solid Organ Transplant RecipientsHanna Kleiboeker, Jillian L Descourouez, Lucas T Schulz, et al.
Pageof 6